4 recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 4 |
Follow Autonomic Dysfunction: new trials by email Literature Review of Autonomic Dysfunction trials Research Report on Autonomic Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autonomic and Renal Contributions to Hypertension With ADT Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Recruiting | Virginia Commonwealth University | 50 | 2026-08-01 | 2026-09-30 |
| Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition 5 mL of 0.25% bupivacaine with epinephrine (1:200,000), Placebo (Saline) Control - Autonomic Dysfunction | Phase 4 | Recruiting | University Health Network, Toronto | 78 | 2026-05-19 | 2026-10-09 |
| LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery Landiolol - Perioperative Myocardial Injury, Autonomic Dysfunction | Phase 4 | Recruiting | Insel Gruppe AG, University Hospital Bern | 114 | 2026-04-24 | 2026-05-05 |
| Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo Vespireit, Arlevert - Vertigo, Autonomic Dysfunction | Phase 4 | Recruiting | Valenta Pharm JSC | 160 | 2024-01-24 | 2025-06-15 |
Primary Dysautonomias (4) · Hypertension (1) · Kidney Diseases (1) · Prostatic Neoplasms (1) · Vertigo (1)
Autonomic Nervous System Diseases (4) · Nervous System Diseases (4) · Cardiovascular Diseases (1) · Ear Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Labyrinth Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Neurologic Manifestations (1) · Otorhinolaryngologic Diseases (1)
Bupivacaine (1) · Epinephrine (1) · Flutamide (1) · Leuprolide (1) · Receptors, Androgen (1) · Saline Solution (1) · Sodium Chloride (1) · bicalutamide (1) · cinnarizine, dimenhydrinate drug combination (1) · landiolol (1)
Insel Gruppe AG, University Hospital Bern (1) · University Health Network, Toronto (1) · Valenta Pharm JSC (1) · Virginia Commonwealth University (1)
Canada (1) · Russia (1) · Switzerland (1) · United States (1)
Anuj Bhatia, MD, PhD (1) · Matthew Babcock, PhD (1)
K01HL164978 (1)